Although mpMRI can improve targeting of clinically significant prostate cancer, its performance depends in part on obtaining ...
Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...
An elevated PSA level in the blood may indicate prostate cancer, but does not yet allow for a definitive diagnosis.
MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests. A new meta-analysis by investigators from Brigham and ...
TORONTO, March 13, 2026 (GLOBE NEWSWIRE)-- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, ...
The first OnQ Prostate-assisted Focal One® Robotic HIFU procedure was successfully performed at UCSF, improving prostate cancer treatment precision. Cortechs.ai and EDAP TMS have announced the ...
There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
The 2026 ProsTIC annual meeting featured a PSMA imaging session and a presentation by Dr. Yao Zhu discussing that PSMA PET will replace painful prostate biopsies. The key message of Dr. Zhu’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results